Auxilium announces IMPRESS trials of XIAFLEX published in Journal of Urology

Auxilium Pharmaceuticals announced that The Journal of Urology has electronically published the uncorrected proof of the company's IMPRESS trials, the phase III studies that assessed XIAFLEX, a novel, in-office, biologic for the potential treatment of Peyronie's disease on its website The manuscript is currently scheduled to appear in print in the July 2013 print version of The Journal of Urology. This publication includes details of the co-primary and secondary families of endpoints.

View Comments (0)